HSBC Holdings’s VivoSim Labs VIVS Stock Holding History

HSBC Holdings’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-69	Closed	-$57K	–	2637
2016 Q4	$57K	Buy	+69	New	+$54.8K	﹤0.01%	2662

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HSBC Holdings's VIVS Position: Q1 2017 in Review

HSBC Holdings sold out of VivoSim Labs (VIVS) in Q1 2017, closing a stake of 69 shares — an estimated $57K sold.

HSBC Holdings first reported a position in VIVS in Q4 2016 and held it in 1 quarter. The position peaked at $57K in Q4 2016. 115 funds tracked by Wall St. Rank hold VIVS as of Q1 2017.

HSBC Holdings reported no remaining VivoSim Labs position as of Q1 2017 after selling out during the quarter.
HSBC Holdings sold 69 VivoSim Labs shares in Q1 2017, an estimated $57K.
HSBC Holdings first reported a position in VivoSim Labs in Q4 2016 and held it in 1 quarter.
HSBC Holdings's VivoSim Labs position peaked at $57K in Q4 2016.
115 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2017.

Based on HSBC Holdings's 13F filing for Q1 2017, filed 15 May 2017.